Cargando…
Small ubiquitin-like modifier 4 M55V polymorphism is not associated with diabetic nephropathy in Iranian type 2 diabetes patients
INTRODUCTION: We studied the impact of small ubiquitin-like modifier 4 (SUMO4) M55V polymorphism on susceptibility to diabetic nephropathy in Iranian type 2 diabetes patients. MATERIALS AND METHODS: The patient group consisted of 50 Iranian type 2 diabetes patients with nephropathy, and the control...
Autores principales: | Shahsavar, Farhad, Jafarzadeh, Mehrzad, Azargoon, Alireza, Hedayati, Mehdi, Asadifar, Behnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758724/ https://www.ncbi.nlm.nih.gov/pubmed/24019619 http://dx.doi.org/10.4103/0971-6866.116121 |
Ejemplares similares
-
Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population
por: Hosseini, Maria, et al.
Publicado: (2021) -
The Role of Ubiquitination and Sumoylation in Diabetic Nephropathy
por: Gao, Chenlin, et al.
Publicado: (2014) -
Association between ELMO1 gene polymorphisms and diabetic nephropathy in an Iranian population
por: Mehrabzadeh, Mohsen, et al.
Publicado: (2016) -
The GSTO2 (rs156697) Polymorphism Modifies Diabetic Nephropathy Risk
por: Pavlovic, Dragana, et al.
Publicado: (2023) -
ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)